BioSmartLtd Balance Sheet Health
Financial Health criteria checks 3/6
BioSmartLtd has a total shareholder equity of ₩146.4B and total debt of ₩73.4B, which brings its debt-to-equity ratio to 50.1%. Its total assets and total liabilities are ₩266.6B and ₩120.1B respectively. BioSmartLtd's EBIT is ₩10.2B making its interest coverage ratio 2.3. It has cash and short-term investments of ₩26.0B.
Key information
50.1%
Debt to equity ratio
₩73.42b
Debt
| Interest coverage ratio | 2.3x |
| Cash | ₩26.00b |
| Equity | ₩146.45b |
| Total liabilities | ₩120.12b |
| Total assets | ₩266.57b |
Recent financial health updates
BioSmartLtd (KOSDAQ:038460) Seems To Be Using A Lot Of Debt
Aug 01
Here's Why BioSmartLtd (KOSDAQ:038460) Has A Meaningful Debt Burden
May 02Is BioSmartLtd (KOSDAQ:038460) Using Too Much Debt?
Mar 09These 4 Measures Indicate That BioSmartLtd (KOSDAQ:038460) Is Using Debt Extensively
Nov 29
Recent updates
BioSmart Co.,Ltd. (KOSDAQ:038460) May Have Run Too Fast Too Soon With Recent 25% Price Plummet
Nov 13Here's Why We Think BioSmartLtd (KOSDAQ:038460) Is Well Worth Watching
Oct 14BioSmartLtd (KOSDAQ:038460) Seems To Be Using A Lot Of Debt
Aug 01BioSmart Co.,Ltd. (KOSDAQ:038460) Might Not Be As Mispriced As It Looks After Plunging 26%
Jun 15Here's Why BioSmartLtd (KOSDAQ:038460) Has A Meaningful Debt Burden
May 02Further Upside For BioSmart Co.,Ltd. (KOSDAQ:038460) Shares Could Introduce Price Risks After 52% Bounce
Apr 11Shareholders In BioSmartLtd (KOSDAQ:038460) Should Look Beyond Earnings For The Full Story
Mar 26Is BioSmartLtd (KOSDAQ:038460) Using Too Much Debt?
Mar 09Returns On Capital At BioSmartLtd (KOSDAQ:038460) Paint An Interesting Picture
Feb 16Declining Stock and Decent Financials: Is The Market Wrong About BioSmart Co.,Ltd. (KOSDAQ:038460)?
Jan 29BioSmartLtd (KOSDAQ:038460) Shareholders Have Enjoyed A 51% Share Price Gain
Jan 11BioSmart Co.,Ltd. (KOSDAQ:038460) Looks Interesting, And It's About To Pay A Dividend
Dec 23Does BioSmart Co.,Ltd. (KOSDAQ:038460) Have A Place In Your Dividend Portfolio?
Dec 17These 4 Measures Indicate That BioSmartLtd (KOSDAQ:038460) Is Using Debt Extensively
Nov 29Financial Position Analysis
Short Term Liabilities: A038460's short term assets (₩140.3B) exceed its short term liabilities (₩93.5B).
Long Term Liabilities: A038460's short term assets (₩140.3B) exceed its long term liabilities (₩26.7B).
Debt to Equity History and Analysis
Debt Level: A038460's net debt to equity ratio (32.4%) is considered satisfactory.
Reducing Debt: A038460's debt to equity ratio has increased from 28.3% to 50.1% over the past 5 years.
Debt Coverage: A038460's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: A038460's interest payments on its debt are not well covered by EBIT (2.3x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/27 16:54 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
BioSmart Co.,Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|